Less than 30% of digital transformations succeed across industries, while biopharma remains significantly behind (~20% succeed), with only a small minority of companies achieving scaled, en
Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.
Eli Lilly has recruited basketball legend Shaquille O'Neal to promote a sleep apnoea awareness campaign and make the case for treatment with Zepbound.
Lilly's Ebglyss has claimed an FDA approval for less-frequent maintenance dosing that could give it an edge over market leader Dupixent.
The EMA has started its review of Bayer's asundexian for secondary stroke prevention, keeping it ahead of a rival drug from BMS and J&J.
Editor's Picks
![Corporate-Survival-Hacks-16x9[2]](https://pharmaphorum.com/wp-content/uploads/2021/07/Corporate-Survival-Hacks-16x92.jpg)
